Drug Type Small molecule drug |
Synonyms FXS7490, XS 02, XS02 |
Target |
Action inhibitors |
Mechanism Chk1 inhibitors(Checkpoint kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Phase 1 | China | 15 Aug 2024 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 15 Aug 2024 | |
| Osteosarcoma | Phase 1 | China | 15 Aug 2024 | |
| Ovarian Cancer | Phase 1 | China | 15 Aug 2024 | |
| Uterine Serous Carcinoma | Phase 1 | China | 15 Aug 2024 | |
| Solid tumor | IND Approval | China | 05 Mar 2024 |





